In the bone cancer pain model, the upregulation of PD-L1 promotes the secretion of CCL2, which selectively activates C-fiber nociceptive neurons in DRG and drives the pathogenesis of bone cancer pain [51]. This evidence concerns the gene CCL2 and bone neoplasm.